Biomarin Pharmaceutical (BMRN) Cash & Current Investments (2009 - 2026)
Biomarin Pharmaceutical's Cash & Current Investments came in at $874.01 million for Q2 2026, down 39.0% from $1.43 billion a year earlier and down 60.7% from the prior quarter.
Powered by 
Analysis
Biomarin Pharmaceutical (BMRN) Cash & Current Investments (2009 - 2026) Analysis & Trends
At the end of FY2025, Biomarin Pharmaceutical's Cash & Current Investments was $1.56 billion, up 37.2% from FY2024.
- Cash & Current Investments carries a five-year compound annual growth rate of 7.9% (FY2020 to FY2025).
- Going back by year, Cash & Current Investments was $1.14 billion in FY2024 (+6.0%), $1.07 billion in FY2023 (-16.9%), $1.29 billion in FY2022 (+27.4%) and $1.01 billion in FY2021 (-4.8%).
- The Q2 2026 figure represents the lowest quarterly Cash & Current Investments since Q1 2020.
- Year-over-year, Cash & Current Investments increased in six of the last eight quarters, with growth averaging 19.9%.
- The fastest year-over-year change in Cash & Current Investments over five years came in Q1 2026 (growth of 74.7%), and the weakest in Q2 2026 (a decline of 39.0%).
- Business Quant data shows BMRN's Cash & Current Investments at $2.22 billion (Q1 2026), $1.56 billion (Q4 2025) and $1.48 billion (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 20.76 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 7.14 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 9.92 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.97 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 11.70 Bn |
| 10 | Biomarin Pharmaceutical | 11.07 Bn | 4.93 Bn | 786.91 Mn | 874.01 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 874.01 Mn |
| Mar 31, 2026 | 2.22 Bn |
| Dec 31, 2025 | 1.56 Bn |
| Sep 30, 2025 | 1.48 Bn |
| Jun 30, 2025 | 1.43 Bn |
| Mar 31, 2025 | 1.27 Bn |
| Dec 31, 2024 | 1.14 Bn |
| Sep 30, 2024 | 930.44 Mn |
| Jun 30, 2024 | 1.22 Bn |
| Mar 31, 2024 | 1.05 Bn |
| Dec 31, 2023 | 1.07 Bn |
| Sep 30, 2023 | 1.13 Bn |
| Jun 30, 2023 | 1.17 Bn |
| Mar 31, 2023 | 1.15 Bn |
| Dec 31, 2022 | 1.29 Bn |
| Sep 30, 2022 | 1.27 Bn |
| Jun 30, 2022 | 1.11 Bn |
| Mar 31, 2022 | 1.06 Bn |
| Dec 31, 2021 | 1.01 Bn |
| Sep 30, 2021 | 1.08 Bn |
API Access
Biomarin Pharmaceutical Cash & Current Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=BMRN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-current-investments", "ticker": "BMRN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=BMRN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();